This research proposal utilizes Plasmodium yoelii, a urine malarial parasite which requires antibodies for resolution of infection. A monoclonal antibody (McAb 302) was constructed which provided dramatic passive protection of mice infected with the erthrocytic stage of this parasite. This antibody possessed the unusual IgG3 isotype and recognized the major merozoite surface antigen, PY230. Subsequent studies have been concerned with the idiotypy of McAb 302, the mechanism responsible for its biological activity and the plasmodial antigen which it recognizes. A portion of the gene encoding the epitope recognized by McAb 302 has been molecularly cloned and sequenced. This analysis has established that the epitope is within the C-terminal portion of the PY230 antigen and that this area of the molecule has significant homology with the PF195 antigen of P. falciparum. Such data supports the contention that the C-terminal region, which is more conserved between strains, contains epitopes which may be important in the induction of protective immune responses to the major merozoite surface antigen. This hypothesis can be approached using the murine model. Several techniques will be utilized to map the epitope recognized by McAb 302. In addition, the remainder of the gene encoding PY230 will be cloned and sequenced. Since the PF195 antigen of P. falciparum is known to be polymorphic, the major merozoite protein will be characterized in other murine plasmodia. These studies will provide the basis for determining important T-cell and B-cell epitopes of PY230. Preliminary studies with bacterial expression plasmids have shown that recombinant PY230 polypeptides can be synthesized in bacterial hosts and subsequently purified. Defined recombinant or synthetic peptides will be used in immunization studies in mice examining alternate conditions of administration and different host strains. Animals determined to be immune to parasite challenge will be further studied to establish whether the protective immunity induced is a reflection of cell-mediated or humoral mechanisms of immunity. This system thus provides a unique model or examining the interaction of the host immune system with defined epitopes of one of the most important malarial antigens described to date.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI021089-06
Application #
3131048
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1985-01-01
Project End
1994-05-31
Budget Start
1991-06-01
Budget End
1994-05-31
Support Year
6
Fiscal Year
1991
Total Cost
Indirect Cost
Name
Allegheny University of Health Sciences
Department
Type
Schools of Medicine
DUNS #
City
Philadelphia
State
PA
Country
United States
Zip Code
19129
Rotman, H L; Daly, T M; Long, C A (1999) Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge. Exp Parasitol 91:78-85
Kang, Y; Calvo, P A; Daly, T M et al. (1998) Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite. J Immunol 161:4211-9
Rotman, H L; Daly, T M; Clynes, R et al. (1998) Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model. J Immunol 161:1908-12
Daly, T M; Long, C A (1996) Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection. Infect Immun 64:2602-8
Calvo, P A; Daly, T M; Long, C A (1996) Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria. Exp Parasitol 82:54-64
Farley, P J; Long, C A (1995) Plasmodium yoelii yoelii 17XL MSP-1: fine-specificity mapping of a discontinuous, disulfide-dependent epitope recognized by a protective monoclonal antibody using expression PCR (E-PCR). Exp Parasitol 80:328-32
Kang, Y; Long, C A (1995) Sequence heterogeneity of the C-terminal, Cys-rich region of the merozoite surface protein-1 (MSP-1) in field samples of Plasmodium falciparum. Mol Biochem Parasitol 73:103-10
Daly, T M; Long, C A (1995) Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria. J Immunol 155:236-43
Farley, P J; Srivastava, R; Long, C A (1994) Sequence of the gene encoding the N-terminal portion of the Plasmodium yoelii yoelii 17XL merozoite surface protein-1 (MSP-1). Gene 151:335-6
Nussenzweig, R S; Long, C A (1994) Malaria vaccines: multiple targets. Science 265:1381-3

Showing the most recent 10 out of 20 publications